FDX
41
11
CL
50
2
M
30
2
WU
36
2
PHM
60
6
HBI
52
2
AAP
30
3
PH
71
4
KSS
42
4
O
33
-4
IVZ
52
6
MHK
46
3
LB
45
15
EQT
30
5
CI
40
2
CA
16
3
WY
53
2
GLW
48
2
V
56
2
CSX
57
4
FDX
41
11
CL
50
2
M
30
2
WU
36
2
PHM
60
6
HBI
52
2
AAP
30
3
PH
71
4
KSS
42
4
O
33
-4
IVZ
52
6
MHK
46
3
LB
45
15
EQT
30
5
CI
40
2
CA
16
3
WY
53
2
GLW
48
2
V
56
2
CSX
57
4
Financhill
Back

CytoMed Therapeutics 10K Form

Buy
75

GDTC
CytoMed Therapeutics

Last Price:
2.49
Seasonality Move:
3.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDTC News And Ratings

See the #1 stock for the next 7 days that we like better than GDTC

GDTC Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.65
Price / Book: 4.04

Profitability

EPS (TTM): -0.19340
Net Income (TTM): $-2.27M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

CytoMed Therapeutics Earnings Forecast

Key CytoMed Therapeutics Financial Ratios

  • The Interest Expense is -1.24% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

CytoMed Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GDTC
Website: w2.cytomed.sg

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GDTC Technical Analysis vs Fundamental Analysis

Buy
75
CytoMed Therapeutics (GDTC) is a Buy

Is CytoMed Therapeutics a Buy or a Sell?